FASN and breast cancer: In this context, several studies conducted in HER2+ breast cancer (BC) revealed the existence of a reciprocal positive feedback loop between HER2 and the lipogenic enzyme FASN [20], whose upregulation can represent an important mechanism of resistance to anti-HER2 agents [19].